Arginine and proline metabolism |    |
Citrullinemia Type I |    |
Carbamoyl Phosphate Synthetase Deficiency |    |
Argininosuccinic Aciduria |    |
D-Arginine and D-Ornithine Metabolism |    |
Urea Cycle |    |
Chlorothiazide Action Pathway |    |
Polythiazide Action Pathway |    |
Methyclothiazide Action Pathway |    |
Bumetanide Action Pathway |    |
Bendroflumethiazide Action Pathway |    |
Quinethazone Action Pathway |    |
Ethacrynic Acid Action Pathway |    |
Hydrochlorothiazide Action Pathway |    |
Cyclothiazide Action Pathway |    |
Metolazone Action Pathway |    |
Hydroflumethiazide Action Pathway |    |
Indapamide Action Pathway |    |
Furosemide Action Pathway |    |
Torsemide Action Pathway |    |
Trichlormethiazide Action Pathway |    |
Chlorthalidone Action Pathway |    |
Triamterene Action Pathway |    |
Amiloride Action Pathway |    |
Spironolactone Action Pathway |    |
Eplerenone Action Pathway |    |
Glucose Transporter Defect (SGLT2) |    |
Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency) |    |
Hartnup Disorder |    |
Iminoglycinuria |    |
Lysinuric Protein Intolerance |    |
Ornithine Transcarbamylase Deficiency (OTC Deficiency) |    |
Prolidase Deficiency (PD) |    |
Prolinemia Type II |    |
Argininemia |    |
Hyperprolinemia Type II |    |
Hyperprolinemia Type I |    |
Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency) |    |
Ornithine Aminotransferase Deficiency (OAT Deficiency) |    |
Kidney Function |    |
Creatine deficiency, guanidinoacetate methyltransferase deficiency |    |
Hyperornithinemia with gyrate atrophy (HOGA) |    |
Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome] |    |
L-arginine:glycine amidinotransferase deficiency |    |
Blue diaper syndrome |    |
Lysinuric protein intolerance (LPI) |    |
Cystinuria |    |